Cancer Research Fund - VHL Alliance
Von Hippel-Lindau disease (VHL) is a rare genetic
disorder characterized by the growth of tumors in
certain parts of the body—the retina, brain, spinal
cord, kidney, pancreas, and adrenal glands—which
often become cancerous. The VHL Family Alliance
was founded in 1993 by Joyce Graff, Susan Warnick,
and Peggy Graham, with three purposes: to raise the
visibility of VHL, to fund research into angiogenesis
especially involving the VHL gene, and to improve
diagnosis, treatment, and quality of life for individuals
and families affected by the VHL and related
tumors. So far they have raised and awarded more
than a million dollars in grants, but the Internet has
transformed their institutional model and influence.
From three families, and with a small staff, their circle
has broadened to more than 15,000 individuals in 102
countries. They have printed materials—including a
Handbook on managing one’s health with the VHL
syndrome—in eight languages, and online discussions
in five. They have been cited in more than 30 medical
journal articles as an excellent resource for patients,
and their Director has been an invited speaker at
medical meetings on four continents. But there is still
no cure, and a great deal yet to be done. You can help.

|